EGFR and adenocarcinoma: H1975 is a human non-small cell lung cancer (NSCLC) adenocarcinoma cell line characterized by concurrent EGFR L858R and T790M mutations, and is widely employed in studies of targeted therapy efficacy and mechanisms of drug resistance in lung cancer.